Balance Sheet
Accounts PayablesCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Intangibles: 2018-2025

Historic Intangibles for Dr Reddys Laboratories (RDY) over the last 8 years, with Mar 2025 value amounting to $1.1 billion.

  • Dr Reddys Laboratories' Intangibles rose 155.98% to $1.1 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $1.1 billion, marking a year-over-year increase of 155.98%. This contributed to the annual value of $1.1 billion for FY2025, which is 155.98% up from last year.
  • According to the latest figures from FY2025, Dr Reddys Laboratories' Intangibles is $1.1 billion, which was up 155.98% from $443.0 million recorded in FY2024.
  • Dr Reddys Laboratories' Intangibles' 5-year high stood at $1.1 billion during FY2025, with a 5-year trough of $359.0 million in FY2022.
  • In the last 3 years, Dr Reddys Laboratories' Intangibles had a median value of $443.0 million in 2024 and averaged $650.7 million.
  • Per our database at Business Quant, Dr Reddys Laboratories' Intangibles dropped by 26.28% in 2022 and then surged by 155.98% in 2025.
  • Over the past 5 years, Dr Reddys Laboratories' Intangibles (MRY) stood at $487.0 million in 2021, then fell by 26.28% to $359.0 million in 2022, then rose by 4.46% to $375.0 million in 2023, then increased by 18.13% to $443.0 million in 2024, then skyrocketed by 155.98% to $1.1 billion in 2025.
  • Its Intangibles stands at $1.1 billion for FY2025, versus $443.0 million for FY2024 and $375.0 million for FY2023.